And we've seen that. AstraZeneca, what they did was that they had this treatment, the actual medication inside did not change at all the administration of it, but they AstraZeneca filed a new patent to maintain exclusivity of [an inhaler pump] without changing the medication inside. great innovation that was worth this not going generic for? I'm not aware, but I think you know the answer. Yeah, it's this little plastic piece right here. (04:13–04:28)
CLAIM
Asserts that AstraZeneca filed a new patent for an inhaler pump without changing the medication to maintain exclusivity.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
